Medistep Healthcare IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Aug 08 to Aug 12 2025
Price Band
₹43
Current GMP
₹53.0(+23.26%)
Subscription
382.08 times
IPO Details
| IPO Date | August 8, 2025 to August 12, 2025 |
| Listing Date | August 18, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹43 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 37,44,000 shares (aggregating up to ₹16.10 Cr) |
| Reserved for Market Maker | 1,89,000 shares (aggregating up to ₹0.8127 Cr)Nirman Share Brokers Pvt.Ltd. |
| Net Offered to Public | 35,55,000 shares (aggregating up to ₹15.29 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,04,65,546 shares |
| Share Holding Post Issue | 1,42,09,546 shares |
IPO Date
August 8, 2025 to August 12, 2025
Listing Date
August 18, 2025
Face Value
₹10 per share
Issue Price
₹43 per share
Lot Size
3,000 Shares
Sale Type
Fresh Capital
Total Issue Size
37,44,000 shares (aggregating up to ₹16.10 Cr)
Reserved for Market Maker
1,89,000 shares (aggregating up to ₹0.8127 Cr)Nirman Share Brokers Pvt.Ltd.
Net Offered to Public
35,55,000 shares (aggregating up to ₹15.29 Cr)
Issue Type
Fixed Price IPO
Listing At
NSE SME
Share Holding Pre Issue
1,04,65,546 shares
Share Holding Post Issue
1,42,09,546 shares
IPO Subscription Details
| Market Maker | 1 |
| Non-Institutional Buyers*** | 289.13 |
| Individual Investors (IND category bidding for 2 Lots) | 461.01 |
| Total ** | 382.08 |
Market Maker
1
Non-Institutional Buyers***
289.13
Individual Investors (IND category bidding for 2 Lots)
461.01
Total **
382.08
Day Wise Sub
| Day | NII* | Individual Investors | Total |
|---|---|---|---|
| Day 1 Aug 8, 2025 | 2.49 | 16.46 | 9.48 |
| Day 2 Aug 11, 2025 | 31.98 | 126.96 | 79.52 |
| Day 3 Aug 12, 2025 | 289.13 | 461.01 | 382.08 |
DayDay 1
Aug 8, 2025
NII*2.49
Individual Investors16.46
Total9.48
DayDay 2
Aug 11, 2025
NII*31.98
Individual Investors126.96
Total79.52
DayDay 3
Aug 12, 2025
NII*289.13
Individual Investors461.01
Total382.08
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 12-08-2025 | 43.00 | 13(30.23%) | 56 |
| 11-08-2025 | 43.00 | 13(30.23%) | 56 |
| 10-08-2025 | 43.00 | 20(46.51%) | 63 |
| 09-08-2025 | 43.00 | 18(41.86%) | 61 |
| 08-08-2025 | 43.00 | 18(41.86%) | 61 |
| 07-08-2025 | 43.00 | 17(39.53%) | 60 |
| 06-08-2025 | 43.00 | 12(27.91%) | 55 |
| 05-08-2025 | 43.00 | 12(27.91%) | 55 |
Date12-08-2025
Price43.00
GMP13(30.23%)
Estimate List Price56
Date11-08-2025
Price43.00
GMP13(30.23%)
Estimate List Price56
Date10-08-2025
Price43.00
GMP20(46.51%)
Estimate List Price63
Date09-08-2025
Price43.00
GMP18(41.86%)
Estimate List Price61
Date08-08-2025
Price43.00
GMP18(41.86%)
Estimate List Price61
Date07-08-2025
Price43.00
GMP17(39.53%)
Estimate List Price60
Date06-08-2025
Price43.00
GMP12(27.91%)
Estimate List Price55
Date05-08-2025
Price43.00
GMP12(27.91%)
Estimate List Price55
IPO Important Dates
| IPO Open Date | Fri, Aug 8, 2025 |
| IPO Close Date | Tue, Aug 12, 2025 |
| Tentative Allotment | Wed, Aug 13, 2025 |
| Initiation of Refunds | Thu, Aug 14, 2025 |
| Credit of Shares to Demat | Thu, Aug 14, 2025 |
| Tentative Listing Date | Mon, Aug 18, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 12, 2025 |
IPO Open Date
Fri, Aug 8, 2025
IPO Close Date
Tue, Aug 12, 2025
Tentative Allotment
Wed, Aug 13, 2025
Initiation of Refunds
Thu, Aug 14, 2025
Credit of Shares to Demat
Thu, Aug 14, 2025
Tentative Listing Date
Mon, Aug 18, 2025
Cut-off time for UPI mandate confirmation
5 PM on August 12, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 6,000 | ₹2,58,000 |
| Individual investors (Retail) (Max) | 2 | 6,000 | ₹2,58,000 |
| HNI (Min) | 3 | 9,000 | ₹3,87,000 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares6,000
Amount₹2,58,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares6,000
Amount₹2,58,000
ApplicationHNI (Min)
Lots3
Shares9,000
Amount₹3,87,000
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 22.99 | 14.96 | 14.66 |
| Total Income | 49.66 | 39.08 | 27.74 |
| Profit After Tax | 4.14 | 3.33 | 0.92 |
| EBITDA | 5.60 | 4.54 | 1.34 |
| Net Worth | 16.83 | 11.69 | 1.07 |
| Reserves and Surplus | 6.37 | 6.79 | |
| Total Borrowing | 0.64 | 0.33 | 0.53 |
Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 202522.99
31 Mar 202414.96
31 Mar 202314.66
Period EndedTotal Income
31 Mar 202549.66
31 Mar 202439.08
31 Mar 202327.74
Period EndedProfit After Tax
31 Mar 20254.14
31 Mar 20243.33
31 Mar 20230.92
Period EndedEBITDA
31 Mar 20255.60
31 Mar 20244.54
31 Mar 20231.34
Period EndedNet Worth
31 Mar 202516.83
31 Mar 202411.69
31 Mar 20231.07
Period EndedReserves and Surplus
31 Mar 20256.37
31 Mar 20246.79
31 Mar 2023
Period EndedTotal Borrowing
31 Mar 20250.64
31 Mar 20240.33
31 Mar 20230.53
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio |
|---|---|---|---|---|---|---|
| Medistep Healthcare Limited | 4.01 | 4.01 | 16.28 | 10.72 | 24.62 | |
| Fabino Enterprises Limited | 0.63 | 0.63 | 20.42 | 41.27 | 3.12 | 1.30 |
| Achyut Healthcare Ltd | 0.02 | 0.02 | 1.33 | 209.00 | 1.77 | 4.00 |
Company NameMedistep Healthcare Limited
EPS (Basic)4.01
EPS (Diluted)4.01
NAV (per share) (Rs)16.28
P/E (x)10.72
RoNW (%)24.62
P/BV Ratio
Company NameFabino Enterprises Limited
EPS (Basic)0.63
EPS (Diluted)0.63
NAV (per share) (Rs)20.42
P/E (x)41.27
RoNW (%)3.12
P/BV Ratio1.30
Company NameAchyut Healthcare Ltd
EPS (Basic)0.02
EPS (Diluted)0.02
NAV (per share) (Rs)1.33
P/E (x)209.00
RoNW (%)1.77
P/BV Ratio4.00
IPO Reservation
| Market Maker Shares Offered | 1,89,000 (5.05%) |
| NII (HNI) Shares Offered | 17,76,000 (47.44%) |
| Retail Shares Offered | 17,79,000 (47.52%) |
| Total Shares Offered | 37,44,000 (100.00%) |
Market Maker Shares Offered
1,89,000 (5.05%)
NII (HNI) Shares Offered
17,76,000 (47.44%)
Retail Shares Offered
17,79,000 (47.52%)
Total Shares Offered
37,44,000 (100.00%)
Information about company
Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company.
The product includes the followings:-
Sanitary Pads: Medistep produces high-quality sanitary pads, addressing essential feminine hygiene needs.
Energy Powder: The company manufactures energy supplements designed to revitalize and invigorate consumers.
Pharmaceutical Products: Medistep engages in the trading of various pharmaceutical items, ensuring accessibility to essential medications.
Nutraceutical Products: They offer products that blend nutrition and pharmaceuticals, promoting overall health and wellness.
Intimate Care and Hygiene Products: The company provides personal hygiene and intimate care products.
Surgical Products: Medistep supplies surgical items and supports medical professionals with necessary tools and equipment.
As of December 30, 2024, Medistep reported annualized revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore.
As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract.
Competitive Strength:
Experienced Promoters and Management Team.
Maximize resources for quality supply and cost savings through economies of scale.
Offers various products, including trading in pharmaceutical and healthcare items, manufacturing DRYSTEP sanitary pads, and VITASTEP Z energy powders.
Objectives of IPO
The Company Medistep Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (₹ in crores)
1
Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
0.51
2
Working Capital requirements
12.34
3
General Corporate Purpose
1.64
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App